This guideline reviews evidence for prognostic tools for patients with advanced incurable cancer in their final months of life. It finds good evidence for certain individual prognostic factors, like performance status, and some physical signs for predicting imminent death, but notes limited data on multivariable models for those receiving disease-modifying therapy.